Madecassol (Centella Asiatica Extract)

Centella asiatica extract stimulates fibroblast activity and collagen production while modulating inflammatory pathways. The resulting effect accelerates re‑epithelialisation, improves granulation tissue formation and helps minimise scar tissue during the wound‑healing process.

The specific amount and frequency of Madecassol application are determined by the prescribing healthcare professional based on the wound type, size and patient condition. No fixed dosing regimen is provided in public documentation.

Safety data for Madecassol in pregnancy and lactation are limited. It is generally advised to avoid use unless the potential benefit outweighs the unknown risk, and to discuss any intended use with a qualified medical practitioner.

To place an order, submit an enquiry on the Madecassol product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Madecassol’s active ingredient, Centella asiatica extract, offers a natural mechanism that enhances collagen synthesis and fibroblast proliferation, which differs from synthetic agents such as silver sulfadiazine or antibiotic ointments. It is generally well tolerated and may be preferred when a non‑antibiotic, plant‑based option is desired.

Store Madecassol at room temperature, ideally below 25 °C. Keep the container tightly closed, protect it from direct sunlight, moisture and extreme temperatures to maintain product stability and potency.

Madecassol is applied topically to clean, dry skin. A thin layer is spread over the affected area using clean hands or a sterile applicator, and the site is then covered with a non‑occlusive dressing if required. Follow the prescriber’s instructions regarding frequency and duration.

The most serious risks include allergic contact dermatitis, severe hypersensitivity reactions such as urticaria or angioedema, and secondary infection of the treated area. Patients should discontinue use and seek medical attention if any signs of a serious reaction develop.

Madecassol should not be used on patients with known hypersensitivity to Centella asiatica or any excipients in the formulation, on open or infected wounds without medical supervision, and on individuals where safety during pregnancy or lactation cannot be assured.